Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study

Zhou, CC; Kim, SW; Reungwetwattana, T; Zhou, JY; Zhang, YP; He, JX; Yang, JJ; Cheng, Y; Lee, SH; Bu, LL; Xu, TT; Yang, L; Wang, C; Liu, T; Morcos, PN; Lu, Y; Zhang, L

Zhang, L (reprint author), Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China.

LANCET RESPIRATORY MEDICINE, 2019; 7 (5): 437

Abstract

Background Anaplastic lymphoma kinase-positive (ALK-positive) disease occurs in approximately 5% of all patients with non-small-cell lung cancer, with......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索